Pivot Pharma Enters Hemp CBD Industry with Acquisition
Ryan Allway
October 23rd, 2017
Exclusive, News, Top News
The hemp industry is expected to reach $1.8 billion over the coming years, driven by the increasing popularity of cannabidiol (CBD) supplements among consumers and the potential being realized by researchers.
Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) aims to capitalize on the market with its recent acquisition of ACI Foods, which holds a hemp cultivation and processing license under Health Canada’s Industrial Hemp Regulations. Investors may want to take a closer look at the stock as it integrates this acquisition with its existing oral and transdermal drug delivery technologies.
Hemp Industry Could Reach $1.8 Billion
Many investors are focused on the marijuana industry following adult-use legalization in Canada and California, but the marijuana plant’s non-psychoactive cousin offers investors another great way to profit within the cannabis industry.
Hemp sales reached $688 million last year, according to the Hemp Business Journal, growing at a 22% compound annual growth rate over the past five years. While personal care products hold the greatest share of the market, hemp-based cannabidiol (CBD) represents the fastest growing subset of the industry with a 53% compound annual growth rate. The analyst projects that U.S. hemp-based CBD product sales will exceed $80 million by 2020.
“Hemp Business Journal estimates the total retail value of all hemp products sold in the U.S. to be at least $688 million for 2016. We estimate the hemp industry will grow to $1.8 billion in sales by 2020, led by hemp food, body care, and CBD-based products. The data demonstrates the hemp industry is growing quickly at 22% five year CAGR and being led by food and body care products, with Hemp CBD products showing a 53% AGR,” said Sean Murphy, the Founder and Publisher of Hemp Business Journal.
At the same time, there’s a growing body of research highlighting the potential benefits of CBD in treating a wide array of medical conditions. Google Scholar includes more than 2,000 research papers submitted this year alone containing the word “cannabidiol”, which range from well-known conditions like Dravet syndrome to potential benefits in treating neuropsychiatric and drug-use disorders along with pain and nerve pain.
Pivot Pharma Acquires ACI Foods
Pivot Pharmaceuticals recently signed a binding letter of intent to acquire Absorbent Concepts Inc., or ACI Foods. With revenue that grew 300% to C$2 million over the past year, the company has become a leading producer of hemp-based food products in Canada’s burgeoning cannabis industry. The company holds both hemp cultivation and processing licenses under Health Canada’s Industrial Hemp Regulations.
In the near-term, the company plans to submit an application to Health Canada for an Authorized Dealer’s License that would enable it to produce and supply CBD oil, as well as conduct cannabinoid research and development. These activities could enable it to provide extract products and edibles and enter the medical side of the cannabinoid business with research and development activities.
“We are excited to welcome ACI Foods to the Pivot family and together look forward to becoming a dominant force in the global hemp industry,” says Pivot CEO Patrick Frankham. “With impressive revenue and rapid growth in only three years of existence, we see an opportunity to help expand ACI Foods to significantly increase product offerings and sales. We consider this acquisition to be a strategic initiative to enable market share dominance in the hemp segment of the cannabis industry. The timing of this acquisition is in anticipation of the forthcoming legislative changes in Canada regarding the legal status of cannabidiol (“CBD”). Accordingly, the recent announcement by the World Anti-Doping Agency (WADA) that CBD will be removed from its list of banned substances effective January 1, 2018, further solidifies Pivot’s strategy of developing fast-to-market cannabinoid based products.”
Pivot Pharma’s historical focus has been on the development of pharmaceuticals and nutraceuticals using its proprietary drug delivery technologies. In particular, the BiPhasix™ Transdermal Drug Delivery platform (dermal) and the Solmic Solubilisation technology (oral) provide unique ways to deliver cannabinoids like CBD and tetrahydrocannabinol (THC). Its initial pipeline includes women’s sexual dysfunction, psoriasis, and cancer supportive care products.
Looking Ahead
Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) represents a compelling opportunity in the global cannabis industry. In addition to a growing pipeline of therapeutic candidates, the company’s acquisition of ACI Foods provides valuable inroads into the hemp-based CBD market with immediate revenue generated by the processing, packaging and distribution of gluten-free, organic hemp-based products. Upon receipt of the Health Canada Dealer’s License, the company projects that revenues from the sale of CBD oils and extracts will be significant.
For more information, visit the company’s website.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Technical420 is the premier provider of research and analysis on cannabis stocks. We provide investors with sponsored and non-sponsored information on the volatile and emerging cannabis industry. “Our research is our passion!” Your profit is our reward!
Matthew Nordgren is an ambitious executive, dedicated philanthropist, and accomplished athlete who brings a unique passion to creating strategic alliances. He has breadth and depth of experience in finance, corporate development, and capital sourcing, as well as in building highly motivated teams of skilled professionals. In 2005, Mr. Nordgren received his education at the University […]
Headquartered in Lakewood, Colo., STWC Holdings is a complete ecosystem of entities and services that support the burgeoning cannabis industry.
Hero Technologies Inc. is a cannabis company working toward a vertically-integrated business model. The company owns a majority stake in BlackBox Systems and Technologies LLC, an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and cultivation of large flowering plants, creating increased harvest efficiencies. The company’s strategic business plan includes cannabis […]
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
